Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,20502,834,1.03 [0.90-1.17],0.7049696039541988
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20452,162,1.01 [0.75-1.37],0.9475728424349964
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22118,161,0.92 [0.67-1.27],0.6234539606161957
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,15618,625,1.15 [0.98-1.33],0.0795295086712192
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22061,104,0.85 [0.56-1.28],0.432173636091296
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21203,75,1.18 [0.79-1.78],0.4172231039741694
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23237,103,0.86 [0.57-1.30],0.4703240663801458
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23232,69,0.84 [0.51-1.40],0.5056177673967837
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20673,52,1.50 [1.01-2.21],0.0432974519131214
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22706,105,1.19 [0.85-1.67],0.3134495140329485
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22666,65,1.22 [0.79-1.87],0.3688399341588915
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23304,67,0.74 [0.43-1.28],0.2828989837547739
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23283,85,1.35 [0.96-1.89],0.0839011942168817
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23280,82,1.37 [0.97-1.92],0.0724897142589481
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Mycoses,22988,56,0.77 [0.43-1.39],0.3833092397132648
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22316,365,1.04 [0.85-1.27],0.6899591108705062
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22063,112,1.27 [0.93-1.72],0.1357782302822857
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22202,251,0.97 [0.76-1.25],0.816470787602591
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",19074,43,1.20 [0.72-2.01],0.4805287325398312
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19084,53,nan [nan-nan],
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19255,224,0.96 [0.74-1.25],0.7533099181032082
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19262,231,0.95 [0.73-1.23],0.6985737270559219
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",19595,564,1.08 [0.92-1.27],0.3202192467720416
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19077,46,0.91 [0.50-1.67],0.7600734913802776
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,20928,873,1.19 [1.05-1.34],0.0067666915773509
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22424,244,1.31 [1.07-1.61],0.0099865036900141
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23015,94,1.32 [0.95-1.82],0.100138137840881
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23389,79,1.27 [0.89-1.82],0.1852570776870769
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Rectum,23212,53,1.07 [0.64-1.78],0.8008458814888367
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23383,59,1.12 [0.71-1.78],0.6159078398962287
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Stomach,23427,45,1.06 [0.61-1.84],0.843937244153718
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm,23239,236,0.95 [0.73-1.23],0.7004012986801984
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23383,98,0.92 [0.61-1.39],0.6836832398967738
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23383,90,1.12 [0.77-1.64],0.5561002325976624
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23322,60,1.40 [0.95-2.06],0.0908543374145135
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Haemangioma, any site",23324,59,1.39 [0.94-2.07],0.098322584781662
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanocytic naevi,23238,229,0.77 [0.58-1.03],0.082789164412462
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23386,104,0.81 [0.53-1.24],0.3304900948809192
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Other benign neoplasms of skin,23296,190,0.81 [0.59-1.10],0.1788120725455412
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of breast,23369,120,1.24 [0.91-1.68],0.1740679677329896
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Leiomyoma of uterus,22955,851,1.00 [0.87-1.15],0.9751902659424044
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22273,232,1.28 [1.03-1.60],0.0256751469265342
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22034,377,1.25 [1.05-1.49],0.0140235998266559
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22034,377,1.25 [1.05-1.49],0.0140235998266559
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),20759,337,1.12 [0.92-1.36],0.2661578036060631
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22918,88,1.14 [0.77-1.67],0.5122227881514745
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23138,81,0.87 [0.55-1.38],0.5585762425052522
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,19443,743,1.19 [1.04-1.36],0.0094614131788127
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,21501,750,1.05 [0.92-1.21],0.4743437736623737
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,21864,91,0.92 [0.60-1.41],0.696612184056098
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22553,48,0.69 [0.36-1.33],0.2701859973364474
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21854,81,1.03 [0.67-1.58],0.8791235478036418
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22117,344,0.93 [0.74-1.16],0.5213996720111312
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22107,334,0.93 [0.74-1.17],0.5271489952170094
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,21683,158,1.02 [0.73-1.43],0.893164054191499
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",21685,155,1.04 [0.74-1.46],0.8037471725376545
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19278,578,1.17 [1.01-1.36],0.0398094575952721
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",18768,68,1.18 [0.78-1.77],0.4396503818999646
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,19238,538,1.18 [1.01-1.37],0.03508758475511
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,18746,46,1.08 [0.63-1.86],0.7677903255328059
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18755,55,1.47 [1.01-2.14],0.046389798037444
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Any mental disorder,19758,509,0.86 [0.72-1.04],0.1224708470124687
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19348,99,0.70 [0.44-1.10],0.1234834531661288
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23215,64,0.94 [0.56-1.57],0.8007505667462171
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23248,39,0.86 [0.43-1.72],0.6649260069440204
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22189,32,0.80 [0.37-1.71],0.5572262315132612
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23385,32,0.83 [0.39-1.77],0.6304006483585343
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",19281,32,0.78 [0.36-1.68],0.5297960223382872
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Alcohol dependence,22181,24,0.94 [0.41-2.17],0.8839269213341165
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Smoking dependency,22112,31,0.53 [0.23-1.25],0.1467386730989285
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19286,37,0.73 [0.36-1.51],0.4002815980956731
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19559,310,0.93 [0.74-1.17],0.5304418236433196
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Depression,21720,277,1.03 [0.82-1.30],0.7899851300550618
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Depression or dysthymia,19380,240,0.95 [0.73-1.23],0.682640105157103
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19376,127,0.92 [0.65-1.31],0.6504648832610445
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Other anxiety disorders,21809,65,0.80 [0.47-1.36],0.4128725536049513
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Neurological diseases,20291,1386,1.05 [0.94-1.16],0.4138675805221555
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18563,166,1.25 [0.96-1.61],0.0926686525055946
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23260,137,1.33 [1.02-1.73],0.0333345089034368
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22324,359,1.20 [0.99-1.44],0.0608609873607711
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Epilepsy,22078,113,1.28 [0.93-1.76],0.1347963489719363
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Migraine,22071,106,1.12 [0.79-1.60],0.5125437749563979
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23051,99,1.19 [0.84-1.69],0.3237701119115105
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22835,51,1.36 [0.89-2.07],0.1547331640318231
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other sleep disorders,22049,84,0.99 [0.64-1.53],0.9740899038151898
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Sleep apnoea,23078,60,1.18 [0.76-1.82],0.4611809236112119
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22244,716,0.96 [0.82-1.11],0.5765438549774778
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21630,102,1.11 [0.77-1.59],0.5762661508747611
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21978,450,0.99 [0.82-1.19],0.8913568493058122
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23208,62,0.51 [0.28-0.95],0.0348723633664005
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Hemiplegia,23193,47,0.54 [0.27-1.09],0.085269401299214
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other neurological diseases,23012,100,0.88 [0.58-1.33],0.5411725140594117
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22805,362,0.87 [0.70-1.08],0.2042012064173448
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22650,207,0.99 [0.75-1.30],0.9418192851123708
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22505,62,0.54 [0.30-1.00],0.050195472433332
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22556,113,0.93 [0.63-1.35],0.6903984320509612
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22532,89,0.91 [0.59-1.40],0.6721669661745451
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,19878,145,0.97 [0.70-1.35],0.8591579587956835
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20082,349,0.99 [0.80-1.22],0.8995002125047076
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22542,151,0.81 [0.57-1.16],0.2513910664420974
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23202,29,0.46 [0.19-1.15],0.0959440244471336
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1492,29,0.52 [0.21-1.31],0.1672973571014524
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",21739,29,0.46 [0.19-1.13],0.0902733691013945
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22837,77,0.81 [0.50-1.32],0.396185122546888
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22801,41,0.63 [0.31-1.30],0.2118007067189841
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22699,76,0.87 [0.54-1.40],0.563129226314105
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22930,87,0.79 [0.49-1.26],0.322684882968727
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23319,104,1.39 [1.03-1.86],0.0303483761214177
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,22759,95,1.03 [0.70-1.53],0.8662134268298927
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,17229,2332,0.95 [0.86-1.04],0.269617080795323
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22949,67,1.15 [0.74-1.77],0.5369311228973117
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",18121,1713,0.94 [0.85-1.05],0.2758328282314125
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypertension,18135,1727,0.94 [0.84-1.05],0.2516450120859894
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16440,32,1.34 [0.78-2.30],0.2923434580053671
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22015,598,0.93 [0.78-1.10],0.3748431671328929
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Angina pectoris,21834,417,0.88 [0.71-1.08],0.2244186798983971
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22867,122,0.85 [0.58-1.24],0.3889518485267668
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22929,184,0.98 [0.73-1.31],0.8890233274470385
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23366,23,1.13 [0.53-2.41],0.7435769232517498
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",21492,75,1.20 [0.81-1.77],0.3662349707581325
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21789,383,0.90 [0.73-1.12],0.3482105665731596
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22746,85,1.23 [0.87-1.76],0.2433923761632784
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22842,181,1.07 [0.82-1.41],0.6144281971743485
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22751,90,0.78 [0.49-1.24],0.2901790826545387
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22751,90,0.78 [0.49-1.24],0.2901790826545387
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16495,87,0.73 [0.45-1.18],0.2031922445173801
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20397,31,0.99 [0.50-1.97],0.9784782759028574
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Conduction disorders,20430,64,1.43 [1.00-2.05],0.0469765911479645
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14098,86,0.71 [0.43-1.16],0.1658751640783184
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,14242,230,1.19 [0.93-1.53],0.1561236844518463
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other arrhythmias,20408,42,1.14 [0.67-1.95],0.6277005109469983
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,20414,48,1.19 [0.73-1.96],0.4834038342902352
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22737,87,0.83 [0.53-1.31],0.4283379987561673
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22759,109,0.69 [0.45-1.06],0.0933609403429575
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22795,83,0.67 [0.40-1.10],0.1158148317900852
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22856,72,0.77 [0.46-1.29],0.3276912843868401
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22574,59,1.18 [0.75-1.85],0.484614082658388
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22610,95,1.18 [0.82-1.69],0.3674728018753059
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22059,106,0.94 [0.64-1.39],0.7570993629470735
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22036,83,0.86 [0.55-1.37],0.5336691094175701
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23237,82,0.85 [0.54-1.35],0.4952932860103443
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Varicose veins,22477,524,1.16 [0.99-1.35],0.0666752534161334
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypotension,22499,70,1.22 [0.81-1.83],0.3385350323557869
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,19041,1794,1.05 [0.95-1.15],0.3450682610462219
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23239,111,1.00 [0.69-1.45],0.989111739374684
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22062,168,1.09 [0.82-1.45],0.5597210684127993
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22045,151,1.05 [0.77-1.43],0.7509106111183232
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22646,201,1.02 [0.78-1.34],0.8678861555866475
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22642,197,1.04 [0.80-1.37],0.7571003615264958
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22771,481,0.85 [0.70-1.04],0.1079964480927206
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Chronic sinusitis,22392,102,1.01 [0.69-1.47],0.9694939054710944
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Nasal polyp,22360,70,1.01 [0.64-1.59],0.972642425658324
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22593,303,0.85 [0.66-1.08],0.1765159548773535
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Deviated nasal septum,22407,117,1.07 [0.76-1.50],0.6997204229568266
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11269,55,0.55 [0.28-1.05],0.0705361019640754
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,20875,992,1.18 [1.05-1.33],0.0044530972612527
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Early onset COPD,22543,128,1.08 [0.78-1.50],0.6451706883009198
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22560,145,1.11 [0.82-1.51],0.4988669626793561
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",22560,145,1.11 [0.82-1.51],0.4988669626793561
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",21639,852,1.19 [1.05-1.34],0.0061253550172162
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Asthma,17403,852,1.17 [1.03-1.32],0.0142448017701702
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",17247,852,1.16 [1.03-1.32],0.0164693763117683
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",17391,840,1.18 [1.04-1.34],0.0085546061096569
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23152,74,1.17 [0.77-1.76],0.4649270518227019
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,21858,57,1.29 [0.84-1.99],0.2442079045854889
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23213,57,1.29 [0.84-1.99],0.2450753857453578
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21853,52,1.37 [0.89-2.10],0.1501365831511392
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pleural effusion,21857,67,0.96 [0.60-1.55],0.8815199740011724
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,21952,162,0.98 [0.72-1.33],0.8986956096416708
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22425,82,1.13 [0.77-1.68],0.5323769963822003
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16258,5099,1.06 [0.99-1.14],0.0720213558993168
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22935,411,1.12 [0.93-1.34],0.2193345001795623
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23386,87,1.04 [0.69-1.57],0.8427264012966399
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Impacted teeth,23391,79,1.05 [0.68-1.61],0.8266488272552341
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Dental caries,22617,93,1.15 [0.79-1.67],0.4784226856056474
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22633,109,1.22 [0.89-1.69],0.218970500888185
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23377,96,1.03 [0.70-1.53],0.8700682990157369
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22623,99,1.07 [0.73-1.55],0.7348928544354545
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22363,68,0.75 [0.44-1.28],0.2959196352658468
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23300,43,1.05 [0.59-1.87],0.8596529034089055
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17721,189,1.06 [0.81-1.39],0.660039526766287
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",19492,1960,1.01 [0.92-1.11],0.8237407939123479
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oesophagitis,17779,247,1.10 [0.88-1.38],0.4121461135430674
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18158,626,0.98 [0.84-1.15],0.8417900018944889
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,17594,62,0.81 [0.47-1.40],0.4594308677670295
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17648,116,1.08 [0.77-1.50],0.6660239696691376
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17564,32,0.97 [0.49-1.92],0.925707276497718
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastric ulcer,17658,126,1.15 [0.84-1.57],0.384715788955146
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Duodenal ulcer,17596,64,1.12 [0.72-1.74],0.6219150550668249
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23346,50,1.00 [0.58-1.72],0.9865123092175386
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Chronic gastritis,17644,112,1.03 [0.72-1.47],0.8897162182393678
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18247,715,1.03 [0.89-1.19],0.7257054884117076
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of appendix,23285,130,1.05 [0.75-1.46],0.7933417824803002
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Functional dyspepsia,18018,486,1.10 [0.93-1.30],0.2725907021385041
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17677,145,0.66 [0.45-0.97],0.0339384644213066
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23304,121,1.06 [0.75-1.49],0.7515707966742122
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute appendicitis,23261,106,1.11 [0.78-1.58],0.5714590263813684
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Hernia,20973,1015,1.11 [0.99-1.25],0.0867700381225529
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Inguinal hernia,20013,55,1.08 [0.66-1.77],0.7524073238508104
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Umbilical hernia,20022,64,1.15 [0.73-1.81],0.5351678699117455
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ventral hernia,20046,88,1.31 [0.93-1.83],0.1207059975625433
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20770,812,1.07 [0.93-1.22],0.331386156313408
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22501,778,1.05 [0.91-1.20],0.4956183849001345
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of intestines,18596,1845,1.07 [0.97-1.17],0.1564521676484067
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23135,57,0.71 [0.39-1.29],0.2622218020311416
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23370,81,0.73 [0.44-1.20],0.2161002779911065
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Crohn disease,21804,81,0.73 [0.45-1.20],0.21928559183657
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21782,59,0.83 [0.48-1.45],0.5159952685101171
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23296,112,1.01 [0.70-1.45],0.9606965413930598
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ulcerative colitis,21835,112,1.01 [0.70-1.45],0.9535431829744352
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21821,98,1.00 [0.68-1.48],0.9924525268079532
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22383,660,1.06 [0.92-1.23],0.424550505957766
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22374,651,1.06 [0.91-1.23],0.4546837399048442
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16837,86,1.24 [0.86-1.79],0.2457766746943769
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Intestinal stricture,23020,86,1.22 [0.85-1.75],0.2908340602392714
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16805,54,1.01 [0.60-1.72],0.9604193064569296
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,17314,563,0.89 [0.75-1.07],0.219610230966126
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16949,198,0.96 [0.72-1.28],0.7735635857038894
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,17079,328,1.05 [0.85-1.30],0.6722853194680432
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Constipation,21993,294,1.07 [0.86-1.33],0.5601468693685856
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of peritoneum,22990,109,1.20 [0.86-1.66],0.2799332444793171
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16858,107,1.04 [0.72-1.50],0.8359154537300855
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16792,41,1.49 [0.95-2.33],0.0844742073301903
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17507,756,1.12 [0.98-1.28],0.1092130642767551
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of intestine,16944,193,1.34 [1.07-1.69],0.0119854273029812
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22979,98,1.08 [0.74-1.56],0.6995814073331801
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of liver,22757,88,1.09 [0.74-1.60],0.6566125403991858
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of liver,22715,46,0.69 [0.35-1.33],0.2652715810212902
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22079,730,0.89 [0.76-1.03],0.1237234209598245
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Cholelithiasis,21958,609,0.91 [0.77-1.07],0.2478197235983938
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Cholecystitis,21458,109,0.85 [0.57-1.27],0.437297094046862
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21402,53,0.84 [0.47-1.51],0.5649373837644048
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute pancreatitis,21399,50,0.87 [0.49-1.55],0.6410558361153043
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23289,50,0.88 [0.50-1.57],0.6647845830469294
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22264,257,1.30 [1.07-1.59],0.0096754769511744
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22098,91,nan [nan-nan],
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Coeliac disease,22085,78,1.36 [0.97-1.91],0.0759740096567046
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22041,34,1.61 [1.05-2.48],0.0292322689093604
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22144,137,1.08 [0.78-1.48],0.6502098275174067
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,GI-bleeding,22136,129,1.06 [0.76-1.47],0.7221728869794044
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,20739,1382,1.05 [0.94-1.16],0.3977318437838781
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23030,100,0.95 [0.64-1.42],0.8156666689207233
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23036,396,1.01 [0.84-1.23],0.8860933183491112
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22086,584,1.02 [0.87-1.20],0.8021256148712106
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22716,283,1.28 [1.05-1.55],0.013044482326742
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22498,65,1.62 [1.17-2.24],0.0033119307610049
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22614,181,1.19 [0.92-1.53],0.1862925898651515
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23168,75,0.92 [0.58-1.47],0.7285330667138048
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23146,53,0.85 [0.48-1.51],0.580656564733524
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23134,41,0.94 [0.50-1.76],0.8507582121447678
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23205,49,0.88 [0.49-1.59],0.6682575410865406
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23202,46,0.91 [0.50-1.66],0.7696775120095389
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22692,52,1.08 [0.65-1.79],0.7626252914365657
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22947,307,0.97 [0.77-1.22],0.7938925359468695
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21580,78,0.78 [0.48-1.27],0.3157373738816564
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21635,133,1.21 [0.91-1.62],0.1980947108567183
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21599,97,1.12 [0.78-1.61],0.5377160888183188
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21723,221,0.89 [0.67-1.18],0.4152887282245029
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21701,199,0.89 [0.66-1.19],0.4247754867159946
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16485,3747,1.03 [0.96-1.11],0.424823356769448
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17983,2155,1.04 [0.95-1.14],0.3643320034357027
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21020,1135,0.96 [0.85-1.09],0.544914829967058
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16016,188,1.38 [1.11-1.72],0.0037176721675109
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16276,448,1.31 [1.12-1.52],0.0005882122980493
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22933,180,1.39 [1.11-1.74],0.0039227684680019
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22947,165,1.37 [1.08-1.74],0.0088909425337117
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16866,1038,1.05 [0.93-1.19],0.3883181837420982
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",19170,1038,1.04 [0.93-1.18],0.4797540273541033
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,15840,12,1.66 [0.94-2.94],0.0825337730253321
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23266,12,1.75 [0.98-3.12],0.0599044963451596
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16060,232,1.27 [1.04-1.56],0.0204420045794649
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,15902,74,0.84 [0.52-1.36],0.481724757665697
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,16090,262,0.84 [0.65-1.09],0.1994754596964542
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23246,134,0.79 [0.54-1.14],0.2082003418713847
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,16228,400,1.06 [0.88-1.27],0.5386178685327514
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16238,410,1.21 [1.03-1.43],0.0219711085533
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,17029,1201,0.94 [0.83-1.06],0.3030680816200825
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),15924,96,1.10 [0.77-1.59],0.5890447017404445
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16180,352,0.94 [0.76-1.17],0.5995804980469094
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,15895,67,0.78 [0.46-1.33],0.3637162764030366
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),15916,88,0.88 [0.57-1.35],0.551116034037605
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16138,310,0.89 [0.71-1.13],0.3388930348572703
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16089,261,0.96 [0.76-1.23],0.7697437050498823
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17430,257,1.00 [0.79-1.28],0.9734510962367572
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22701,206,1.12 [0.86-1.45],0.4008777601072972
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22577,82,1.39 [1.00-1.94],0.0502525448210457
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20059,73,1.00 [0.64-1.57],0.9983653171684946
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20253,267,1.09 [0.87-1.36],0.4622518142493588
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,20865,879,0.99 [0.86-1.13],0.8634301008153655
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20171,185,1.15 [0.89-1.48],0.2985932279859976
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20054,68,0.90 [0.55-1.48],0.6856484025808491
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",20687,701,0.98 [0.84-1.14],0.7631039201362719
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20029,43,1.14 [0.68-1.92],0.6247728303006985
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20194,208,1.09 [0.84-1.41],0.5147484137887178
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20074,88,0.89 [0.58-1.38],0.6099853284663019
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20062,76,0.94 [0.59-1.48],0.7751209426852338
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20112,126,1.10 [0.79-1.53],0.5698146760564136
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20053,67,1.30 [0.87-1.93],0.1979045496555217
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20295,309,0.98 [0.78-1.22],0.8488828679479793
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20207,322,0.96 [0.76-1.20],0.6905944509144828
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19947,62,0.55 [0.30-1.02],0.0560851863819538
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19976,91,0.96 [0.63-1.45],0.8358942244150744
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20002,117,1.23 [0.90-1.69],0.1933711851469541
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19921,36,0.96 [0.50-1.86],0.9146595432910172
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19935,50,1.20 [0.75-1.94],0.4466182203002863
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19922,37,1.23 [0.72-2.11],0.4495197910156763
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20117,232,1.10 [0.87-1.41],0.4208629437525437
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19935,50,0.94 [0.53-1.67],0.8351609704451846
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19941,56,1.10 [0.67-1.79],0.7140921553399477
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20000,115,1.05 [0.74-1.49],0.7910889170441491
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19956,71,0.79 [0.47-1.33],0.3791847270682651
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20352,467,0.87 [0.72-1.06],0.1686474642595733
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20052,167,0.85 [0.62-1.18],0.342186664739073
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20142,257,0.84 [0.65-1.10],0.2038166914980054
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,21084,208,1.07 [0.82-1.38],0.6178160197684636
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,21282,406,1.07 [0.89-1.29],0.4783139537063294
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20910,34,1.23 [0.70-2.14],0.4690582997855759
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20923,47,1.36 [0.87-2.12],0.1779148454058904
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20963,87,1.21 [0.84-1.74],0.306129652718939
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19233,5210,1.05 [0.98-1.11],0.1606771581858932
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,21464,151,1.28 [0.98-1.67],0.0668797644889829
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21350,37,1.22 [0.71-2.10],0.4669685567625822
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21635,27,1.20 [0.63-2.30],0.5749919762688667
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21637,29,1.93 [1.32-2.81],0.000671494862895
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21636,28,1.57 [0.97-2.53],0.065850285072256
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23216,104,1.18 [0.84-1.66],0.3390300338082644
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23127,53,0.69 [0.37-1.29],0.2457275869749829
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23191,79,1.29 [0.89-1.85],0.1744219621549102
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23142,30,0.97 [0.46-2.03],0.9367594028547602
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21566,1069,1.02 [0.91-1.15],0.725893673849435
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Cystitis,20602,105,1.12 [0.79-1.59],0.5112720758453928
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20569,72,1.00 [0.63-1.57],0.9885060624350976
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20636,139,1.20 [0.90-1.60],0.209322483827868
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20578,81,1.20 [0.82-1.76],0.3416760014233314
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21342,845,1.01 [0.88-1.15],0.9289884117436422
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23169,417,1.11 [0.93-1.33],0.262018403152198
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22881,129,1.23 [0.91-1.66],0.1718178945631263
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,22893,141,0.82 [0.57-1.18],0.2777772087786495
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22855,103,1.05 [0.72-1.52],0.7958571783050096
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23095,479,1.11 [0.94-1.32],0.2212782969366347
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,22733,117,1.06 [0.75-1.50],0.7376444622311148
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22827,211,1.20 [0.94-1.52],0.140546128274977
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,21362,3888,1.03 [0.96-1.10],0.4317029984123159
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Endometriosis,17775,301,0.85 [0.66-1.09],0.1970111747350945
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,17558,84,0.96 [0.62-1.48],0.8566291113819678
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17612,138,0.81 [0.56-1.18],0.2734178438801348
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18150,676,1.00 [0.86-1.16],0.9871478032593776
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17812,338,0.93 [0.74-1.16],0.5038975969817496
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18278,804,1.10 [0.96-1.26],0.1560147138507598
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17741,267,1.12 [0.90-1.40],0.3160888862077132
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17848,374,0.95 [0.77-1.17],0.6176178000089413
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,17555,81,1.29 [0.92-1.82],0.1394342667847055
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,17640,166,1.20 [0.91-1.57],0.1935045037553677
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",23388,230,1.12 [0.88-1.43],0.3686820625055589
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,23397,218,1.11 [0.86-1.43],0.4179227172866645
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,23418,118,1.08 [0.76-1.52],0.6685497796574883
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",23410,130,1.13 [0.82-1.55],0.4683102683397245
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17596,122,0.82 [0.56-1.21],0.320091432158596
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17573,99,1.19 [0.84-1.69],0.320632404113828
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17594,120,1.07 [0.76-1.51],0.6857966835650167
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Irregular menses,23330,391,0.97 [0.79-1.18],0.7414749971555772
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18612,1138,0.98 [0.87-1.11],0.7518604878758844
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18218,744,0.98 [0.84-1.14],0.7641905591672724
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",23404,170,0.93 [0.68-1.27],0.635620298890005
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17865,391,1.03 [0.85-1.26],0.7348452919570985
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17732,258,0.82 [0.62-1.07],0.1373879039157672
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18252,778,1.08 [0.94-1.24],0.2603320696288793
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Female infertility,17558,84,1.01 [0.66-1.55],0.954970785186674
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",17551,77,0.99 [0.63-1.56],0.9744354655818196
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,23415,719,0.99 [0.84-1.17],0.9237584342014612
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,23422,990,1.02 [0.88-1.18],0.8132258827037442
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,23415,375,1.12 [0.91-1.37],0.2759647139868945
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,23145,105,0.71 [0.45-1.13],0.1470956795403419
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,23192,152,1.35 [1.04-1.76],0.0235866814630366
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,23173,133,1.14 [0.83-1.59],0.4182241213660798
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",23431,139,0.78 [0.53-1.13],0.188094206837315
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,23433,137,0.76 [0.52-1.11],0.1552498449392194
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,23429,352,0.89 [0.70-1.12],0.3180391242754667
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,23179,102,1.22 [0.87-1.70],0.2547010169473704
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,23276,199,0.95 [0.71-1.28],0.7392861657794223
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,22820,124,1.03 [0.71-1.48],0.8848355892028937
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,22859,163,0.88 [0.62-1.24],0.4631565368922613
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,22896,200,1.14 [0.87-1.48],0.3443607803132004
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,22817,121,0.97 [0.67-1.43],0.8962623070738311
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,22809,113,1.22 [0.87-1.70],0.2454143171823976
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,22819,123,0.88 [0.59-1.30],0.5124106936892527
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,22623,191,1.05 [0.79-1.39],0.7231241844093645
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],22800,368,1.12 [0.92-1.37],0.2658379234794943
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,22983,551,1.10 [0.92-1.32],0.2851542717625464
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",23435,145,1.01 [0.72-1.41],0.9719957429567272
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,22234,110,0.88 [0.58-1.34],0.5528991523126033
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",22517,85,1.04 [0.67-1.60],0.8727753250175763
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,23440,280,1.07 [0.84-1.36],0.5930915411989914
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,23379,219,1.01 [0.76-1.33],0.9596274284686942
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",23429,203,1.12 [0.86-1.46],0.4013025959713854
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",23420,194,1.13 [0.86-1.49],0.3674112691030049
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23182,41,1.31 [0.79-2.16],0.2976479590340551
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,20977,533,0.81 [0.67-0.98],0.0301307720808436
